The DRC ‘mystery illness’ shows why the U.S. can’t ‘pause’ infectious disease work
We may have an answer to the “mystery illness” in the Democratic Republic of Congo. Here’s what the story reveals about America’s global health commitments.
We may have an answer to the “mystery illness” in the Democratic Republic of Congo. Here’s what the story reveals about America’s global health commitments.
Depemokimab is an ultra-long-acting biologic therapy with enhanced binding affinity for interleukin-5 that may enable effective 6-month dosing intervals. In these phase 3A, randomized, placebo-cont…
Worldwide, approximately 2 million children younger than 15 years of age are infected with multidrug-resistant (MDR) Mycobacterium tuberculosis, with MDR tuberculosis developing in approximately 30…
Cachexia is a common complication of cancer and is associated with an increased risk of death. The level of growth differentiation factor 15 (GDF-15), a…
This Medical News article is an interview with FDA Commissioner Robert Califf, MD, about the agency’s regulatory powers over artificial intelligence tools for use in…
If you’ve been diagnosed with melanoma, what are the chances it will come back? An oncologist explains what you need to know about recurrent melanoma.
THURSDAY, Dec. 19, 2024 (HealthDay News) — Sleep apnea is known to wreak havoc with the body, contributing to heart problems, diabetes and liver disease.The…
For some time, I’ve been an admirer of many of the articles published on Sensible Medicine, a site that usually features articles written by physicians…
Nutrition and fitness advice from our experts, straight to your inbox.
Even small asteroids can do a lot of damage—and new research shows the James Webb Space Telescope is adept at spotting the tiniest of space…
Help us reach our goal! Your support will make a meaningful difference. Every contribution brings us closer to success. Join us today and be part…